Hologic Stock Net Asset

HOLX Stock

USD 66.04 0.09 0.14%

By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Hologic's long-term financial health and intrinsic value.

Short Long Term Debt Total Total Assets

Build AI portfolio with Hologic Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Hologic Company Net Asset Analysis

Hologic's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current Hologic Net Asset

9.16 B

Most of Hologic's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Hologic Net Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Hologic is extremely important. It helps to project a fair market value of Hologic Stock properly, considering its historical fundamentals such as Net Asset. Since Hologic's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hologic's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hologic's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Short Term Investments	Common Stock	Long Term Debt	Treasury Stock	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Good Will	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.76	0.19	0.24	0.54	0.59	0.7	0.62	0.0	0.34	0.75	0.66	-0.43	0.37	0.76	0.68	0.87	0.2	0.56	0.67	-0.13	-0.7	-0.14	0.38	0.22	0.42	0.47
Total Stockholder Equity	0.76		-0.48	0.79	0.6	-0.04	0.98	0.82	-0.25	0.71	0.49	0.06	-0.87	-0.3	0.57	0.66	0.61	0.77	0.02	0.86	-0.66	-0.41	-0.28	0.62	0.32	0.86	0.76
Net Debt	0.19	-0.48		-0.87	-0.11	0.81	-0.55	-0.33	0.39	-0.56	0.24	0.75	0.74	0.93	0.13	-0.09	0.24	-0.89	0.67	-0.4	0.78	-0.3	0.28	-0.39	-0.14	-0.75	-0.5
Retained Earnings	0.24	0.79	-0.87		0.31	-0.56	0.82	0.53	-0.46	0.78	-0.03	-0.45	-0.88	-0.73	0.12	0.27	0.11	0.93	-0.34	0.62	-0.76	0.13	-0.41	0.62	0.31	0.88	0.71
Net Receivables	0.54	0.6	-0.11	0.31		0.13	0.62	0.82	0.09	0.24	0.63	0.13	-0.66	-0.19	0.61	0.73	0.51	0.5	-0.11	0.67	-0.64	-0.64	0.07	0.14	0.12	0.55	0.32
Total Liab	0.59	-0.04	0.81	-0.56	0.13		-0.11	-0.03	0.31	-0.4	0.68	0.95	0.32	0.85	0.64	0.39	0.71	-0.59	0.77	0.05	0.55	-0.6	0.14	-0.27	-0.02	-0.28	-0.23
Total Current Assets	0.7	0.98	-0.55	0.82	0.62	-0.11		0.8	-0.3	0.69	0.46	0.01	-0.92	-0.39	0.54	0.65	0.53	0.83	-0.02	0.87	-0.73	-0.41	-0.35	0.6	0.26	0.91	0.75
Accounts Payable	0.62	0.82	-0.33	0.53	0.82	-0.03	0.8		0.04	0.51	0.64	-0.02	-0.78	-0.31	0.6	0.79	0.53	0.7	-0.23	0.83	-0.78	-0.63	0.06	0.43	0.27	0.71	0.58
Short Term Debt	0.0	-0.25	0.39	-0.46	0.09	0.31	-0.3	0.04		-0.44	0.26	0.02	0.3	0.35	0.18	0.13	0.11	-0.35	-0.22	-0.17	0.21	-0.37	0.92	-0.44	-0.27	-0.38	-0.35
Short Term Investments	0.34	0.71	-0.56	0.78	0.24	-0.4	0.69	0.51	-0.44		-0.01	-0.27	-0.61	-0.46	0.1	0.23	0.11	0.7	-0.1	0.65	-0.53	0.09	-0.44	0.95	0.56	0.61	0.85
Common Stock	0.75	0.49	0.24	-0.03	0.63	0.68	0.46	0.64	0.26	-0.01		0.61	-0.35	0.28	0.95	0.93	0.9	0.11	0.29	0.65	-0.21	-0.89	0.16	0.02	0.12	0.37	0.19
Long Term Debt	0.66	0.06	0.75	-0.45	0.13	0.95	0.01	-0.02	0.02	-0.27	0.61		0.24	0.82	0.58	0.34	0.69	-0.51	0.91	0.1	0.5	-0.55	-0.15	-0.11	0.01	-0.19	-0.12
Treasury Stock	-0.43	-0.87	0.74	-0.88	-0.66	0.32	-0.92	-0.78	0.3	-0.61	-0.35	0.24		0.65	-0.43	-0.61	-0.36	-0.94	0.32	-0.78	0.89	0.29	0.28	-0.46	-0.22	-0.97	-0.61
Intangible Assets	0.37	-0.3	0.93	-0.73	-0.19	0.85	-0.39	-0.31	0.35	-0.46	0.28	0.82	0.65		0.19	-0.07	0.35	-0.83	0.78	-0.32	0.81	-0.33	0.2	-0.3	-0.09	-0.65	-0.37
Property Plant Equipment	0.76	0.57	0.13	0.12	0.61	0.64	0.54	0.6	0.18	0.1	0.95	0.58	-0.43	0.19		0.93	0.93	0.19	0.31	0.7	-0.23	-0.76	0.07	0.12	0.15	0.48	0.29
Current Deferred Revenue	0.68	0.66	-0.09	0.27	0.73	0.39	0.65	0.79	0.13	0.23	0.93	0.34	-0.61	-0.07	0.93		0.82	0.43	0.03	0.82	-0.51	-0.79	0.09	0.21	0.21	0.63	0.39
Good Will	0.87	0.61	0.24	0.11	0.51	0.71	0.53	0.53	0.11	0.11	0.9	0.69	-0.36	0.35	0.93	0.82		0.09	0.48	0.62	-0.07	-0.7	0.02	0.15	0.22	0.4	0.29
Net Tangible Assets	0.2	0.77	-0.89	0.93	0.5	-0.59	0.83	0.7	-0.35	0.7	0.11	-0.51	-0.94	-0.83	0.19	0.43	0.09		-0.52	0.7	-0.94	-0.07	-0.28	0.55	0.22	0.92	0.67
Long Term Debt Total	0.56	0.02	0.67	-0.34	-0.11	0.77	-0.02	-0.23	-0.22	-0.1	0.29	0.91	0.32	0.78	0.31	0.03	0.48	-0.52		-0.01	0.6	-0.22	-0.39	0.07	0.04	-0.25	-0.01
Capital Surpluse	0.67	0.86	-0.4	0.62	0.67	0.05	0.87	0.83	-0.17	0.65	0.65	0.1	-0.78	-0.32	0.7	0.82	0.62	0.7	-0.01		-0.67	-0.48	-0.22	0.6	0.41	0.81	0.83
Deferred Long Term Liab	-0.13	-0.66	0.78	-0.76	-0.64	0.55	-0.73	-0.78	0.21	-0.53	-0.21	0.5	0.89	0.81	-0.23	-0.51	-0.07	-0.94	0.6	-0.67		0.2	0.13	-0.4	-0.13	-0.84	-0.52
Accumulated Depreciation	-0.7	-0.41	-0.3	0.13	-0.64	-0.6	-0.41	-0.63	-0.37	0.09	-0.89	-0.55	0.29	-0.33	-0.76	-0.79	-0.7	-0.07	-0.22	-0.48	0.2		-0.23	0.04	0.05	-0.23	-0.01
Short Long Term Debt	-0.14	-0.28	0.28	-0.41	0.07	0.14	-0.35	0.06	0.92	-0.44	0.16	-0.15	0.28	0.2	0.07	0.09	0.02	-0.28	-0.39	-0.22	0.13	-0.23		-0.47	-0.3	-0.38	-0.37
Long Term Investments	0.38	0.62	-0.39	0.62	0.14	-0.27	0.6	0.43	-0.44	0.95	0.02	-0.11	-0.46	-0.3	0.12	0.21	0.15	0.55	0.07	0.6	-0.4	0.04	-0.47		0.49	0.48	0.8
Net Invested Capital	0.22	0.32	-0.14	0.31	0.12	-0.02	0.26	0.27	-0.27	0.56	0.12	0.01	-0.22	-0.09	0.15	0.21	0.22	0.22	0.04	0.41	-0.13	0.05	-0.3	0.49		0.26	0.52
Net Working Capital	0.42	0.86	-0.75	0.88	0.55	-0.28	0.91	0.71	-0.38	0.61	0.37	-0.19	-0.97	-0.65	0.48	0.63	0.4	0.92	-0.25	0.81	-0.84	-0.23	-0.38	0.48	0.26		0.66
Capital Stock	0.47	0.76	-0.5	0.71	0.32	-0.23	0.75	0.58	-0.35	0.85	0.19	-0.12	-0.61	-0.37	0.29	0.39	0.29	0.67	-0.01	0.83	-0.52	-0.01	-0.37	0.8	0.52	0.66

Click cells to compare fundamentals

Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.

Competition

Predict Hologic

Hologic Total Assets

Total Assets

11.06 Billion

At this time, Hologic's Total Assets are fairly stable compared to the past year.

Based on the recorded statements, Hologic has a Net Asset of 9.16 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.

Hologic Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hologic's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics of similar companies.

Hologic is currently under evaluation in net asset category among its peers.

Hologic ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Hologic's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Hologic's managers, analysts, and investors.

Environmental

Governance

Social

Hologic Institutional Holders

Institutional Holdings refers to the ownership stake in Hologic that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Hologic's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Hologic's value.

		Shares
Bank Of America Corp	2025-03-31	3 M
Northern Trust Corp	2025-03-31	3 M
Macquarie Group Ltd	2025-03-31	3 M
First Trust Advisors L.p.	2025-03-31	2.9 M
Dimensional Fund Advisors, Inc.	2025-03-31	2.8 M
Manufacturers Life Insurance Co	2025-03-31	2.8 M
Bnp Paribas Investment Partners Sa	2025-03-31	2.7 M
Ubs Group Ag	2025-03-31	2.5 M
Nordea Investment Mgmt Bank Demark A/s	2025-03-31	2.4 M
Vanguard Group Inc	2025-03-31	26.8 M
Blackrock Inc	2025-03-31	21.4 M

Hologic Fundamentals

	Return On Equity	0.12
	Return On Asset	0.0692
	Profit Margin	0.14 %
	Operating Margin	0.22 %
	Current Valuation	15.61 B
	Shares Outstanding	222.84 M
	Shares Owned By Insiders	0.85 %
	Shares Owned By Institutions	99.15 %
	Number Of Shares Shorted	5.58 M
	Price To Earning	10.21 X
	Price To Book	3.18 X
	Price To Sales	3.65 X
	Revenue	4.03 B
	Gross Profit	2.46 B
	EBITDA	1.3 B
	Net Income	789.5 M
	Cash And Equivalents	2.39 B
	Cash Per Share	9.59 X
	Total Debt	2.66 B
	Debt To Equity	0.57 %
	Current Ratio	3.90 X
	Book Value Per Share	20.73 X
	Cash Flow From Operations	1.29 B
	Short Ratio	2.01 X
	Earnings Per Share	2.38 X
	Price To Earnings To Growth	1.46 X
	Target Price	70.07
	Number Of Employees	7.06 K
	Beta	0.56
	Market Capitalization	14.7 B
	Total Asset	9.16 B
	Retained Earnings	2.85 B
	Working Capital	2.79 B
	Current Asset	137.94 M
	Current Liabilities	39.47 M
	Net Asset	9.16 B

About Hologic Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

VALE	Vale SA ADR
EGY	Vaalco Energy
CMCSA	Comcast Corp

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC